Drugs / Shenfu Injection
Shenfu Injection
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02709798 | Apr 2016 → Feb 2018 | myocardial infarction | Beijing Anzhen Hospital | Completed | Missed primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Shenfu Injection | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02709798 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “Shenfu injection is a traditional Chinese medicine formulation that alleviates ischemia-reperfusion injury through multiple pharmacologic effects.” PMID 34926601 ↗ Dec 2021 |
| Route | Intravenous | “intravenous Shenfu injection (80 ml Shenfu injection + 70 ml 5% glucose injection)” PMID 34926601 ↗ Dec 2021 |